Detailed Information on Publication Record
2011
The atherogenic index of plasma is increased by hormonal contraception
SOŠKA, Vladimír, Jindřich FIALA, Kateřina NEBESKÁ, Jiří JARKOVSKÝ, Drahoslava HRUBÁ et. al.Basic information
Original name
The atherogenic index of plasma is increased by hormonal contraception
Authors
SOŠKA, Vladimír (203 Czech Republic, guarantor, belonging to the institution), Jindřich FIALA (203 Czech Republic, belonging to the institution), Kateřina NEBESKÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution) and Drahoslava HRUBÁ (203 Czech Republic, belonging to the institution)
Edition
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, NORWAY, TAYLOR & FRANCIS AS, 2011, 0036-5513
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30201 Cardiac and Cardiovascular systems
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.156
RIV identification code
RIV/00216224:14110/11:00056966
Organization unit
Faculty of Medicine
UT WoS
000288126400004
Keywords in English
Oral contraceptives; dyslipidemias; cardiovascular diseases; risk factors; HDL cholesterol; triglycerides; C-reactive protein
Tags
International impact
Změněno: 12/4/2012 09:40, Mgr. Michal Petr
Abstract
V originále
The aim of this study was to determine if hormonal contraceptives affect the new atherogenic index of plasma (AIP) = log[triglycerides (TG)/high-density lipoprotein cholesterol (HDL-C)] together with the total cholesterol/HDL-C (TC/HDL-C) and the apolipoprotein B/apolipoprotein A1 (apoB/apoA1) ratios. The increased AIP and hs-CRP concentration after 9 months of hormonal contraception demonstrate that contraceptive-induced dyslipidemia has a proatherogenic nature, even when the TC/HDL-C and the apoB/apoA1 ratios are unchanged.
Links
NR8841, research and development project |
|